4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
9.77
-0.30 (-2.98%)
Apr 21, 2026, 4:00 PM EDT - Market closed
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $497.61 million as of April 21, 2026. Its market cap has increased by 272.51% in one year.
Market Cap
497.61M
Enterprise Value
10.75M
1-Year Change
272.51%
Ranking
Category
Stock Price
$9.77
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $497.61M, a decrease of -14.26%. That is a compound annual growth rate of -2.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 514.09M | 19.97% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 540.02M |
| ADC Therapeutics | 539.94M |
| Valneva SE | 535.43M |
| Immix Biopharma | 534.89M |
| Candel Therapeutics | 528.84M |
| Fulcrum Therapeutics | 528.81M |
| AgomAb Therapeutics NV | 525.87M |
| Zura Bio | 509.51M |